Skip to main content
SpringerLink
Log in

Pancreatic neuroendocrine tumors: Overview of recent advances and diagnosis

  • Published:
Journal of Gastrointestinal Surgery

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Alexander RA, Jensen RT. Pancreatic endocrine tumors. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lippin-cott Williams & Wilkins, 2001, 1788–1813.

    Google Scholar 

  2. Mansour JC, Chen H. Pancreatic endocrine tumors. J Surg Res 2004;120:139–160.

    Article  PubMed  CAS  Google Scholar 

  3. Jensen RT. Natural history of digestive endocrine tumors. In: Mignon M, Colombel JF, eds. Recent Advances in Path-ophysiology and Management of Inflammatory Bowel Dis-eases and Digestive Endocrine Tumors. Paris: John Libbey Eurotext, 1999, pp 192–219.

    Google Scholar 

  4. Corleto VD, Delle Fave G, Jensen RT. Molecular insights into gastrointestinal NE tumors: importance and recent ad-vances. Dig Liver Dis 2002;34:668–680.

    Article  PubMed  CAS  Google Scholar 

  5. Jensen RT. Endocrine tumors of the pancreas. In: Yamada T, Alpers DH, Kaplowitz N, eds. Textbook of Gas-troenterology. Philadelphia: Lippincott Williams and Wilkins, 2003, 2108–2146.

    Google Scholar 

  6. Kwekkeboom D, Krenning EP, deJong M. Peptide receptor imaging and therapy. J Nucl Med 2000;41:1704–1713.

    PubMed  CAS  Google Scholar 

  7. Gibril F, Schumann M, Pace A, et al. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. A prospec-tive study of 107 cases and comparison with 1009 patients from the literature. Medicine 2004;83:43–83.

    Article  PubMed  Google Scholar 

  8. Norton JA, Jensen RT. Resolved and unresolved controver-sies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg 2004;240:757–773.

    Article  PubMed  Google Scholar 

  9. Gumbs AA, Moore PS, Falconi M, et al. Review of the clin-ical, histological, and molecular aspects of pancreatic endo-crine neoplasms. J Surg Oncol 2002;81:45–53.

    Article  PubMed  CAS  Google Scholar 

  10. Gibril F, Jensen RT. Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion. Curr Gastroenterol Rep 2004;6:454–463.

    Article  PubMed  Google Scholar 

  11. Roy P, Venzon DJ, Shojamanesh H, et al. Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine 2000;79:379–411.

    Article  PubMed  CAS  Google Scholar 

  12. Corleto VD, Annibale B, Gibril F, et al. Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome? Aliment Pharmacol Ther 2001;15:1555–1561.

    Article  PubMed  CAS  Google Scholar 

  13. Weber HC, Venzon DJ, Lin JT, et al. Determinants of met-astatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995;108:1637–1649.

    Article  PubMed  CAS  Google Scholar 

  14. Yu F, Venzon DJ, Serrano J, et al. Prospective study of the clinical course, prognostic factors and survival in patients with longstanding Zollinger-Ellison syndrome. J Clin Oncol 1999;17:615–630.

    PubMed  CAS  Google Scholar 

  15. Madeira I, Terris B, Voss M, et al. Prognostic factors in pa-tients with endocrine tumours of the duodenopancreatic area. Gut 1998;43:422–427.

    Article  PubMed  CAS  Google Scholar 

  16. Sutliff VE, Doppman JL, Gibril F, et al. Growth of newly di-agnosed, untreated metastatic gastrinomas and predictors of growth patterns. J Clin Oncol 1997;15:2420–2431.

    PubMed  CAS  Google Scholar 

  17. Jensen RT. Zollinger-Ellison syndrome. In: Doherty GM, Skogseid B, eds. Surgical Endocrinology: Clinical Syn-dromes. Philadelphia: Lippincott Williams & Wilkins, 2001, pp 291–344.

    Google Scholar 

  18. Berger AC, Gibril F, Venzon DJ, et al. Prognostic value of initial fasting serum gastrin level in patients with Zollin-ger-Ellison syndrome. J Clin Oncol 2001;19:3051–3057.

    PubMed  CAS  Google Scholar 

  19. Thompson NW. Current concepts in the surgical manage-ment of multiple endocrine neoplasia type 1 pancreatic-duo-denal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycemia or both. J Intern Med 1998;243:495–500.

    Article  PubMed  CAS  Google Scholar 

  20. Gullo L, Migliori M, Falconi M, et al. Nonfunctioning pan-creatic endocrine tumors: a multicenter clinical study. Am J Gastroenterol 2003;98:2435–2439.

    Article  PubMed  Google Scholar 

  21. Peghini PL, Iwamoto M, Raffeld M, et al. Overexpression of epidermal growthfactor and hepatocyte growth factor receptors in a proportionof gastrinomas correlates with aggressive growth and lower curability. Clin Cancer Res 2002;8:2273–2285.

    PubMed  CAS  Google Scholar 

  22. Goebel SU, Iwamoto M, Raffeld M, et al. HER-2/neu ex-pression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness. Cancer Res 2002;62:3702–3710.

    PubMed  CAS  Google Scholar 

  23. Gibril F, Jensen RT. Diagnostic uses of radiolabelled soma-tostain-receptor analogues in gastroenteropancreatic endo-crine tumors. Dig Liver Dis 2004;36:S106-S120.

    Article  PubMed  CAS  Google Scholar 

  24. Schillaci O, Spanu A, Scopinaro F, et al. Somatostatin recep-tor scintigraphy with 111 Inpentetreotide in non-functioning gastroenteropancreatic NE tumors. Int J Oncol 2003;23:1687–1695.

    PubMed  CAS  Google Scholar 

  25. Gibril F, Reynolds JC, Doppman JL, et al. Somatostatin re-ceptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann Intern Med 1996; 125:26–34.

    PubMed  CAS  Google Scholar 

  26. Anderson MA, Carpenter S, Thompson NW, et al. Endo-scopic ultrasound is highly accurate and directs management in patients with NE tumors of the pancreas. Am J Gastroen-terol 2000;95:2271–2277.

    Article  CAS  Google Scholar 

  27. Sundin A, Eriksson B, Bergstrom M, et al. PET in the diag-nosis of NE tumors. Ann N Y Acad Sci 2004;1014:246–257.

    Article  PubMed  CAS  Google Scholar 

  28. Goebel SU, Heppner C, Burns AD, et al. Geneotype/pheno-type correlations of MEN1 gene mutations in sporadic gas-trinoma. J Clin Endocrinol Metab 2000;85:116–123.

    Article  PubMed  CAS  Google Scholar 

  29. Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999;341:635–644.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. NIDDK, NIH, 10 Center Drive, MSC 1804, Bldg. 10, Room 9C-103, 20892-1804, Bethesda, MD

    Robert T. Jensen M.D.

Authors
  1. Robert T. Jensen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jensen, R.T. Pancreatic neuroendocrine tumors: Overview of recent advances and diagnosis. J Gastrointest Surg 10, 324–326 (2006). https://doi.org/10.1016/j.gassur.2005.08.022

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.gassur.2005.08.022

Keywords

Search

Navigation